DrugBank Announces Leadership Transition as Company Accelerates into AI-Driven Future
DrugBank, the premier provider of structured biomedical intelligence, today announced a strategic leadership transition designed to propel the company's next phase of AI-powered innovation and global growth. Effective October 6, Lisa Downey has been appointed Chief Executive Officer (CEO), while Mike Wilson, DrugBank's Co-Founder, will transition from CEO to Chief Product Officer (CPO), focusing on […]